BIOSCIENCE NEUTRACEUTICALS, INC. Stock-Based Compensation
BIOSCIENCE NEUTRACEUTICALS, INC. reported Stock-Based Compensation of $421.91 thousand for the 12-month period ending 2019-12-31, per its 10-K filed 2020-03-30.
Discontinued › Cash Flow › Operating Activities
us-gaap:ShareBasedCompensation · last filed 2020-03-30
- BIOSCIENCE NEUTRACEUTICALS, INC. share-based payment arrangement, noncash expense for the quarter ending 2019-06-30 was $0.00.
- BIOSCIENCE NEUTRACEUTICALS, INC. share-based payment arrangement, noncash expense for the quarter ending 2019-03-31 was $421.91K.
- BIOSCIENCE NEUTRACEUTICALS, INC. share-based payment arrangement, noncash expense for fiscal 2019 was $421.91K.
| Period end | Share-based Payment Arrangement, Noncash Expense 3 month | Share-based Payment Arrangement, Noncash Expense 6 month | Share-based Payment Arrangement, Noncash Expense 12 month |
|---|---|---|---|
| 2019-12-31 | $421.91K 10-K · filed 2020-03-30 | ||
| 2019-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-12 | $421.91K 10-Q · filed 2019-08-12 | |
| 2019-03-31 | $421.91K 10-Q · filed 2019-05-15 |